Migration of mesenchymal stem cells through cerebrospinal fluid into injured spinal cord tissue.
about
Functional recovery and neural differentiation after transplantation of allogenic adipose-derived stem cells in a canine model of acute spinal cord injuryThe immunomodulatory and neuroprotective effects of mesenchymal stem cells (MSCs) in experimental autoimmune encephalomyelitis (EAE): a model of multiple sclerosis (MS)Mesenchymal stem cell-based treatments for stroke, neural trauma, and heat strokeEffects of bone marrow stromal cell transplantation through CSF on the subacute and chronic spinal cord injury in rats.Transplantation of canine umbilical cord blood-derived mesenchymal stem cells in experimentally induced spinal cord injured dogsEstablishment of a canine spinal cord injury model induced by epidural balloon compression.Bone marrow transplantation restores epidermal basement membrane protein expression and rescues epidermolysis bullosa model mice.Direct evidence of mesenchymal stem cell tropism for tumor and wounding microenvironments using in vivo bioluminescent imaging.Mesenchymal stem cells as therapeutics and vehicles for gene and drug deliveryExtracellular matrix degradation products and low-oxygen conditions enhance the regenerative potential of perivascular stem cells.Dihydropyrimidine Dehydrogenase Is a Prognostic Marker for Mesenchymal Stem Cell-Mediated Cytosine Deaminase Gene and 5-Fluorocytosine Prodrug Therapy for the Treatment of Recurrent Gliomas.Cell Therapy From Bench to Bedside Translation in CNS Neurorestoratology Era.Tracking of mesenchymal stem cells labeled with gadolinium diethylenetriamine pentaacetic acid by 7T magnetic resonance imaging in a model of cerebral ischemia.The influence of cerebrospinal fluid on epidermal neural crest stem cells may pave the path for cell-based therapy.In vivo Differentiation Potential of Mesenchymal Stem Cells: Prenatal and Postnatal Model Systems.Effects of cytokines and chemokines on migration of mesenchymal stem cells following spinal cord injury.A systematic review of cellular transplantation therapies for spinal cord injury.A safety study on intrathecal delivery of autologous mesenchymal stromal cells in rabbits directly supporting Phase I human trials.Spinal cord injury in rats treated using bone marrow mesenchymal stem-cell transplantationCell-free derivatives from mesenchymal stem cells are effective in wound therapy.Transplantation of mesenchymal stem cells in a laryngeal carcinoma patient with radiation myelitis.Effects of Magnetically Guided, SPIO-Labeled, and Neurotrophin-3 Gene-Modified Bone Mesenchymal Stem Cells in a Rat Model of Spinal Cord Injury.Neurorestoration induced by mesenchymal stem cells: potential therapeutic mechanisms for clinical trials.The potential of stem cell therapies for neurological diseases.Doxorubicin Cardiotoxicity and Cardiac Function Improvement After Stem Cell Therapy Diagnosed by Strain Echocardiography.Bone marrow stromal cells for repair of the spinal cord: towards clinical application.Evaluation of neural plasticity in adult stem cells.Keratinocyte Induced Differentiation of Mesenchymal Stem Cells into Dermal Myofibroblasts: A Role in Effective Wound Healing.Kallikrein transduced mesenchymal stem cells protect against anti-GBM disease and lupus nephritis by ameliorating inflammation and oxidative stressA clinical trial report of autologous bone marrow-derived mesenchymal stem cell transplantation in patients with spinal cord injuryTreatment of spinal cord injury by transplantation of cells via cerebrospinal fluidConcise review: Bone marrow for the treatment of spinal cord injury: mechanisms and clinical applications.New strategies in cord blood cells transplantation.Clinical applications of mesenchymal stem cellsCellular therapeutics delivery to the spinal cord: technical considerations for clinical application.Mesenchymal stem cell therapy for the treatment of amyotrophic lateral sclerosis: signals for hope?Increased invasiveness of osteosarcoma mesenchymal stem cells induced by bone-morphogenetic protein-2.Decidua mesenchymal stem cells migrated toward mammary tumors in vitro and in vivo affecting tumor growth and tumor development.High-cell density-induced VCAM1 expression inhibits the migratory ability of mesenchymal stem cells.A gene delivery system with a human artificial chromosome vector based on migration of mesenchymal stem cells towards human glioblastoma HTB14 cells.
P2860
Q24646113-F12E6F0B-C769-4851-A6E8-451E1FE46B4BQ26823691-D9E1267B-35FE-4365-B5ED-AF7BD2D073B0Q28066324-18BBA927-33B4-415C-A1D1-C6CCD6B72DC4Q31139130-F16945E7-4EEF-4EA7-81C6-9863A9AD9FD3Q33843806-CA2B49F7-A590-4EA1-8A4A-4DDF815ED884Q33860788-8CDA27DB-FB6B-4CBF-A4B3-ADFF5D8849DFQ34069632-8BF0A92E-4764-4D71-90C2-CAED1F05C091Q34162598-EB670493-DAD8-4461-98A1-9D18D95B1D67Q34349428-654F964A-0667-4C2B-9C97-7E19E27A6792Q34447292-655FCF7D-5758-4CDF-8FB4-F066C4774317Q34534990-A0502534-44B1-4309-96E6-75C9FB859FF8Q34595662-B464E990-C4F1-40B4-ACF7-5E34BB49697DQ34673375-D88A2F64-AE80-4E46-8E0F-DCB898EAB591Q34835589-64345032-5345-4A23-80EA-5CB078FB00B0Q34870479-2ADCDFBB-09DC-4C6D-9062-A5AD310F05C8Q35120149-15CC686F-CD15-4DCB-9D09-ACB70F6AD37BQ35127777-E08F3FE6-1992-48D3-A92B-8A8B2C8B5A0FQ35598216-5F6770A5-2A37-430B-B5C9-4C7EF69137A0Q35959608-996B4A7A-CE65-4706-8341-03F86EC757FBQ36237928-65513640-5B3F-456E-B6A1-74FAC38743FFQ36252703-0E41441F-B511-4E29-B964-4F6699255D99Q36329015-9DC8476E-101C-43BA-A23B-906AC19FB18EQ36347990-B8BF454A-8E9B-479D-96EF-F645C41159CCQ36390804-4B3F74AF-C13C-4A68-897B-85783D0FD825Q36650772-94AC463F-7ACA-4C4F-8747-E22D6D83273EQ36687134-FFF7A415-5860-4DAC-BE84-5F7D97BC24A5Q36729333-0C0499C8-E0EA-44FF-A865-783D5F8010F4Q36992459-E68FF5F1-34D9-4F96-A141-A949876FDC2DQ37039091-15EE353E-38A6-49EC-9BE1-687BBB634C87Q37075524-6B70F2C8-C1CC-4E68-B86C-8E334AF8EA77Q37288413-4FD7C908-AAF9-4A09-8801-F27E1F2C2853Q37898082-982AEA85-F8D0-438C-A61F-C878C269E57CQ38099291-1D35FA61-0A94-4D66-BCF7-EF3FDB294093Q38122364-A784CE2C-CDEF-4243-9D23-856F7E04B437Q38162491-88E7973C-0ED2-4E92-BF68-11F02BB9A1FEQ38265205-7745A086-DE69-4657-B8A6-97DA197740C4Q39177327-3E2F35D9-BD57-4BF6-AF7F-089B3C0763C5Q39265654-3EADD98A-6877-4C68-AF27-1E7B71CA18C9Q39632527-3317AE65-87A9-4908-8C89-F94354BE2522Q39827109-AF97844C-F134-468F-9481-4E8B53078000
P2860
Migration of mesenchymal stem cells through cerebrospinal fluid into injured spinal cord tissue.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Migration of mesenchymal stem ...... to injured spinal cord tissue.
@en
Migration of mesenchymal stem ...... to injured spinal cord tissue.
@nl
type
label
Migration of mesenchymal stem ...... to injured spinal cord tissue.
@en
Migration of mesenchymal stem ...... to injured spinal cord tissue.
@nl
prefLabel
Migration of mesenchymal stem ...... to injured spinal cord tissue.
@en
Migration of mesenchymal stem ...... to injured spinal cord tissue.
@nl
P1433
P1476
Migration of mesenchymal stem ...... to injured spinal cord tissue.
@en
P2093
Jueren Lou
Kotaro Satake
P304
P356
10.1097/01.BRS.0000138273.02820.0A
P407
P577
2004-09-01T00:00:00Z